palladium has been researched along with Iris Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaugule, SS; Finger, PT | 1 |
Furutani, KM; Pulido, JS; Rogers, DW; Stafford, SL; Thomson, RM | 1 |
Finger, PT; Milman, T; Petousis, V | 1 |
Finger, PT; Yousef, YA | 1 |
Finger, PT | 1 |
5 other study(ies) available for palladium and Iris Neoplasms
Article | Year |
---|---|
Regression Patterns of Iris Melanoma after Palladium-103 (
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brachytherapy; Child; Disease Progression; Female; Follow-Up Studies; Humans; Iris; Iris Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Staging; Ophthalmoscopy; Palladium; Radioisotopes; Radiotherapy Dosage; Retrospective Studies; Time Factors; Treatment Outcome; Ultrasonography; Visual Acuity; Young Adult | 2017 |
Modified COMS plaques for 125I and 103Pd iris melanoma brachytherapy.
Topics: Brachytherapy; Equipment Design; Humans; Iodine Radioisotopes; Iris Neoplasms; Melanoma; Palladium; Radioisotopes; Radiotherapy Dosage | 2010 |
Multifocal iris melanoma treated with total anterior segment palladium-103 plaque radiation therapy.
Topics: Aged; Biopsy; Brachytherapy; Female; Humans; Iris Neoplasms; Melanoma; Neoplasms, Multiple Primary; Palladium; Radioisotopes; Treatment Outcome; Ultrasonography; Visual Acuity | 2011 |
Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Cataract; Female; Follow-Up Studies; Fovea Centralis; Humans; Iris Neoplasms; Lens, Crystalline; Macula Lutea; Male; Melanoma; Middle Aged; Optic Disk; Organs at Risk; Palladium; Radioisotopes; Radiotherapy Dosage; Retinal Diseases; Retrospective Studies; Risk Assessment; Visual Acuity | 2012 |
Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
Topics: Brachytherapy; Cataract; Ciliary Body; Female; Humans; Iris Neoplasms; Lens, Crystalline; Male; Melanoma; Palladium; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Treatment Outcome; Ultrasonography; Uveal Neoplasms; Visual Acuity | 2001 |